Much has been written about divorce being on the rise in India, sometimes accompanied by hand-wringing about the egos and inflexibility of younger couples, who seem less willing than their parents to stay in marriages they are not happy with. National statistics don’t exist on divorce in India, but some local records do show a rise. Still, some experts say the divorce rate in India continues to be artificially low, because...

The 'Food Security' Bill falls flat as its content does not match its aspirations A disconnect runs through the nomenclature, preamble, objectives and content of the National Food Security Bill, 2011. The Preamble goes beyond the Title and states that the Bill provides “for food and nutritional security in human life cycle approach, by ensuring access to adequate quantity of quality food at affordable price….” Even on cursory reading, it is...

The proposed amendments to marriage laws lack the detail to guarantee women their full due   The cabinet’s decision to clear a Bill providing for amendment to marriage laws has evoked mixed reactions within women’s organisations. While the introduction of the notion of matrimonial property within Indian family laws is a welcome move, the manner in which it is being done seems hasty and without due consideration of its implementability. There is...

The Budget provides proof of the United Progressive Alliance government having forgotten the importance of its own “flagship schemes”. BUDGET 2012-13 provides conclusive proof that the United Progressive Alliance (UPA) government has lost its way. It has managed the remarkable feat of upsetting almost everyone and making no one happy. The Budget is highly regressive in both taxation and spending terms and will raise prices of essentials, so aam aurat and...

-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...